A cognitive bias we all have is extrapolation. We take the current situation and project it far into the future assuming it’ll look exactly like today. It is easy to take today’s coronavirus world, extrapolate it, and imagine a future… Read More
We recently moved Wells Fargo to the category “Source of Funds”. If we need to buy a new position or add to an existing position and cash is not readily available in your account, we may sell part or all of your… Read More
Schwab is cutting commissions to 0%! Starting on October 7 all U.S. traded ETFs, stocks, and options will trade commission free. Schwab will still charge $0.65 per contract on options trades. Schwab is a discount broker. Clearly they just erased… Read More
Since 2010 Starbucks (SBUX) has grown its quarterly dividend at a compound annual growth rate of 24.53%! In this video, we discuss the catalysts that will allow Starbucks to continue to grow its dividend each year. We also cover the… Read More
We closed out the remaining positions in Qualcomm for all accounts in the AMM Dividend Growth Strategy*. One of the main reasons we sell a position is when a fundamental change occurs to the underlying business model. Qualcomm’s very profitable… Read More
Intuit’s QuickBooks Online is its Software As A Service (SAAS) business. It is replacing Intuit’s legacy QuickBooks Desktop software. QuickBooks Online is part of Intuit’s effort to transform its revenue from highly repeatable transactional sales to highly recurring subscriptions. I… Read More
DowDuPont (DWDP) is a special situation investment that pays a menaingful dividend. As we discussed in AMM Dividend Letter #37 we added DowDuPont to our dividend growth strategy bcause of its upcoming spin-offs. In the video below, we discuss the… Read More
This morning JP Morgan Chase announced their new commission-free mobile brokerage platform, a trading app. New accounts will get 100 free trades during their first year and if they maintain a balance greater than $15,000 they will continue to get… Read More
Citron Research tweeted on July 19 that AbbVie is the next great drug short. $ABBV the next great drug short. TGT price $60 Gottlieb’s comments for biosimilars and the removal of safe harbor is a DIRECT hit on Abbvie’s abuse… Read More
GE recently announced that a part of its ongoing restructuring effort it will spin-off its GE Healthcare division. GE will spin off 80% of the company to shareholders and then “monetize”, sell, their remaining 20% stake. The announcement peaked… Read More
Bonds are essentially loans. You give a company or some other entity money, they pay you interest, and eventually give you your original investment